Milasen | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

38 results for “Milasen”

Trials

View all 25 →

RADIOSO MILAN I (RADar Reflector localisatiOn-SCOUT for carcinOma Mammae, the MILAN IEO Experience I)

300 participants · First posted Jul 27, 2023

Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCC

39 participants · First posted Jun 21, 2024

Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria

252 participants · First posted Mar 19, 2018

Drugs

PPARα/γ Agonist(University of Milan)

Organizations

MCLAREN MACOMB

United States

McLaren Resources Inc

Mclaren Northern Michigan

United States

News

NCL Translational Research Conference Highlights Advances in Batten Disease Therapies

Milken Institute and Ann Theodore Foundation Launch $575,000 Grant for mTOR Inhibitor Trial in Cutaneous Sarcoidosis

Milken Institute and Ann Theodore Foundation Award $600,000 to Early-Career Sarcoidosis Researchers, Launch Second Funding Cycle

Page 1 of 4